Menopausal Estrogen Therapy Doesn't Appear To Sharpen Women's Brains, No Matter When They Go On It
Going on hormone therapy after menopause doesn't improve women's memory and thinking ability, no matter when they begin the treatment, according to a growing body of research. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - July 22, 2016 Category: Pharmaceuticals Authors: Rita Rubin Source Type: news

Hormone Therapy: No Effect on Cognition After Menopause Hormone Therapy: No Effect on Cognition After Menopause
The first randomized trial to look specifically at timing of hormone therapy with estradiol on cognition has shown no effect in early or late postmenopausal women. Medscape Medical News (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - July 21, 2016 Category: Psychiatry Tags: Neurology & Neurosurgery News Source Type: news

Medical News Today: Postmenopausal hormone therapy has no effect on memory
One of the first large-scale, long-term studies to investigate the effects of hormone therapy on memory in postmenopausal women draws a blank. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 21, 2016 Category: Consumer Health News Tags: Menopause Source Type: news

Hormone therapy for brain performance: No effect, whether started early or late
Hormone therapy has a negligible effect on verbal memory and other mental skills regardless of how soon after menopause a woman begins therapy, new research shows. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - July 21, 2016 Category: Science Source Type: news

Hormone Therapy Won't Help Memory After Menopause
Title: Hormone Therapy Won't Help Memory After MenopauseCategory: Health NewsCreated: 7/19/2016 12:00:00 AMLast Editorial Review: 7/20/2016 12:00:00 AM (Source: MedicineNet Womens Health General)
Source: MedicineNet Womens Health General - July 20, 2016 Category: OBGYN Source Type: news

Hormone Therapy Won't Help Memory After Menopause
5-year study found no difference in thinking skills, with or without estrogen treatment (Source: WebMD Health)
Source: WebMD Health - July 19, 2016 Category: Consumer Health News Source Type: news

Hormone therapy won't help memory after menopause
Steven Reinberg, HealthDay News Women who take estrogen after menopause may believe it helps them maintain their memory and thinking skills, but a new study suggests they are mistaken. (Source: Health News - UPI.com)
Source: Health News - UPI.com - July 19, 2016 Category: Consumer Health News Source Type: news

Hormone Therapy Won't Help Memory After Menopause
5-year study found no difference in thinking skills, with or without estrogen treatment Source: HealthDay Related MedlinePlus Pages: Hormone Replacement Therapy, Memory, Menopause (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - July 19, 2016 Category: Consumer Health News Source Type: news

Hormone Therapy Won't Help Memory After Menopause
5-year study found no difference in thinking skills, with or without estrogen treatment Source: HealthDay Related MedlinePlus Pages: Hormone Replacement Therapy, Memory, Menopause (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - July 19, 2016 Category: Consumer Health News Source Type: news

Hormone Therapy Won't Help Memory After Menopause
TUESDAY, July 19, 2016 -- Women who take estrogen after menopause may believe it helps them maintain their memory and thinking skills, but a new study suggests they are mistaken. Researchers found no change in mental ability associated with... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 19, 2016 Category: Journals (General) Source Type: news

Hormone Therapy Won't Help Memory After Menopause
TUESDAY, July 19, 2016 -- Women who take estrogen after menopause may believe it helps them maintain their memory and thinking skills, but a new study suggests they are mistaken. Researchers found no change in mental ability associated with... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 19, 2016 Category: Journals (General) Source Type: news

Does hormone therapy after menopause affect memory?
(American Academy of Neurology) Contrary to popular belief, taking estrogen after menopause may not affect the memory and thinking abilities of healthy women no matter when the treatment is started. The research is published in the July 20, 2016, online issue of Neurology, the medical journal of the American Academy of Neurology. The recent study is among the first large, long-term clinical trial to examine the cognitive effects of estradiol, a type of estrogen, on women both close to and long after menopause. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - July 19, 2016 Category: Global & Universal Source Type: news

Metabolic Effects of Hormone Therapy in Transgender PatientsMetabolic Effects of Hormone Therapy in Transgender Patients
What do we know about the safety and effects of transgender hormone therapy? Endocrine Practice (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 12, 2016 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

VTE Risk With Use of Hormone Therapy in Postmenopausal WomenVTE Risk With Use of Hormone Therapy in Postmenopausal Women
This study is the first to include both local and systemic use, route of administration, and progestogen component in assessing the risk of VTE in peri- and postmenopausal women using hormone therapy. Menopause (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 12, 2016 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health Journal Article Source Type: news

Researchers developing quick, inexpensive test to assess ER+ breast cancers
(Case Western Reserve University) Researchers from Case Western Reserve University are teaming with industry and other academics to develop a quick and inexpensive test to predict which women with ER+ breast cancer need chemotherapy and which need only the more tolerable hormonal therapy. The National Cancer Institute has awarded the group $3.3 million to support the effort. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - July 11, 2016 Category: Biology Source Type: news

6 Surprising Insights About Sex From A Sex Doctor
Many people are desperately seeking great sex in ordinary life but are entirely at a loss of how to achieve it. Our culture today is riddled with contrasting and confusing messages about sexuality. Beer commercials insist everyone is having spontaneous, sexy fun at every given moment. Institutions ranging from religious leaders, politicians, to our parents and even our own children are chastising us for every possible expression of a sexual existence. With all of these mixed messages abounding us, what in fact is a thriving sexuality supposed to look like? We all know sex is complicated. Having a unique job of talking wi...
Source: Healthy Living - The Huffington Post - July 7, 2016 Category: Consumer Health News Source Type: news

Love Will Be The Death Of Us
Notes On The End Of My Marriage Author's note: This is a sincere attempt to learn the end of a relationship, a final love letter, of sorts. Some of the names have been changed and my former partner has consented its publication. 8.2011 -- The Beginning There is no easy way to masturbate into a small plastic container. I find this out as I approach climax, simultaneously holding the container in place while stoking my erection with the other hand. Truth be told, I don't actually masturbate very often -- perhaps something about the act I continue to find shameful. Suddenly: a rush of white light and a moment of fleeting ...
Source: Healthy Living - The Huffington Post - June 25, 2016 Category: Consumer Health News Source Type: news

Herbal remedies improve early menopause symptoms
A new study finds that plant-based supplements can offer some relief for menopausal symptoms. More than half of menopausal women experience hot flashes. Though prescription hormone therapy effectively treats this symptom, many women, who worry about possible negative health effects from these drugs, opt instead to use herbal remedies. (Source: CNN.com - Health)
Source: CNN.com - Health - June 22, 2016 Category: Consumer Health News Source Type: news

NICE fast-tracks approval of new skin cancer treatment
Patients in England to be first in Europe to access immunotherapy to stall cancer progressRelated items from OnMedicaStudy shows huge global variation in cancer drug costsMeeting cancer promises and more – a new model for NHS diagnostics?Ten year hormonal therapy cuts breast cancer relapse Cancer treatment good but aftercare less soPut case for adding leukaemia drug to Cancer Drugs Fund, NICE tells company (Source: OnMedica Latest News)
Source: OnMedica Latest News - June 17, 2016 Category: UK Health Source Type: news

Long-acting opioids linked to raised mortality
Increased risk of all-cause deaths in people taking long-acting opioids for non-cancer painRelated items from OnMedicaStudy shows huge global variation in cancer drug costsTen year hormonal therapy cuts breast cancer relapse Cancer treatment good but aftercare less soPut case for adding leukaemia drug to Cancer Drugs Fund, NICE tells companyConcern over high death rates for teenage cancer (Source: OnMedica Latest News)
Source: OnMedica Latest News - June 16, 2016 Category: UK Health Source Type: news

Breast cancer patients likely to skip follow-up therapy if not treating other chronic ills
(Columbia University's Mailman School of Public Health) Patients who did not adhere to their medication schedule for chronic conditions, such as hypertension, diabetes, and thyroid disease, prior to a breast cancer diagnosis were twice as likely to skip oral adjuvant hormonal therapy. Patients who skipped medications for their chronic conditions had a 23 percent non-adherence rate to hormone treatment, compared with 10 percent for those who took one or more drugs for their conditions prior to a breast cancer diagnosis. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 9, 2016 Category: Cancer & Oncology Source Type: news

Ten years of hormone breast cancer drugs 'may benefit some'
Conclusion This trial suggests that extending the duration of aromatase inhibitor treatment for postmenopausal women to 10 years, rather than five, may reduce the risk of the cancer recurring or new cancer developing in the other breast. The trial has many strengths, including: a double-blind design, with neither participants nor the research team aware of allocation to treatment or placebo groups – this is regarded as the gold standard of assessing the effect of an intervention; adherence rates to five years were equivalent in both groups (62% in each), suggesting that participants were unaware of treat...
Source: NHS News Feed - June 6, 2016 Category: Consumer Health News Tags: Cancer Medication Source Type: news

Harvard study shows breast cancer patients 'should stay on drugs for 10 years'
Women were 34 per cent less likely to see their cancer return and 20 per cent less likely to die if they took hormone therapy drugs for 10 years rather than five, Harvard Medical School experts found. (Source: the Mail online | Health)
Source: the Mail online | Health - June 6, 2016 Category: Consumer Health News Source Type: news

Ten year hormonal therapy cuts breast cancer relapse
Study suggests recurrence risk is cut by a thirdRelated items from OnMedicaHigh insulin levels linked to worse prognosis in advanced breast cancerHigh white blood cell ratio linked to recurrent cancerPartial radiotherapy suitable for early breast cancerRadiotherapy during breast cancer surgery cuts cost and time (Source: OnMedica Latest News)
Source: OnMedica Latest News - June 6, 2016 Category: UK Health Source Type: news

Cancer treatment good but aftercare less so
Scotland publishes cancer patient surveyRelated items from OnMedicaTen year hormonal therapy cuts breast cancer relapse Lung cancer surgery survival increasesEU membership best for cancer patients and research, say leading oncologistsEnd-of-life care heading for ‘meltdown’ without cash boost, warns cancer charity chiefNHS England promises world-class cancer services (Source: OnMedica Latest News)
Source: OnMedica Latest News - June 6, 2016 Category: UK Health Source Type: news

Extending anti-estrogen therapy to 10 years reduces breast-cancer recurrence, new cancers
CHICAGO — Researchers said extending anti-estrogen hormone therapy to 10 years reduces the risk of a recurrence of breast cancer in many older women and decreases the chance of a new cancer emerging in the other, healthy breast. The study, which was released Sunday at the annual meeting of the American Society of Clinical Oncology, […] (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - June 5, 2016 Category: Consumer Health News Authors: Laurie McGinley Tags: biomedical research cancer Source Type: news

Could statins prevent breast cancer returning?
Conclusion The study aimed to identify biological pathways that could be the reason why some ER+ breast cancers relapse after oestrogen-blocking treatment. It seems that one of the answers for treatment resistance lies in increased activity of cholesterol-producing pathways in the absence of oestrogen. The cholesterol molecules mimic oestrogen and stimulate further tumour growth. The researchers hope that their research could potentially highlight a new pathway, which could be used as a target for therapeutic treatment in the future. Dr Lesley-Ann Martin from the research team told the media, "This is hugely significa...
Source: NHS News Feed - June 2, 2016 Category: Consumer Health News Tags: Cancer Medication Source Type: news

Estrogen Benefits Bones in Transgender Hormone ConversionEstrogen Benefits Bones in Transgender Hormone Conversion
One year of transgender hormone therapy shows the greatest increase in bone-mineral density in male-to-female conversions, while female-to-male conversions benefit most in postmenopausal women. Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - June 1, 2016 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news

GMC stands by guidance urging GPs to prescribe hormones to trans patients
The GMC has defended its advice that GPs should prescribe hormone therapy to transgender patients in some cases, despite GPC concerns that it would push them to prescribe beyond their competence. (Source: GP Online News)
Source: GP Online News - May 31, 2016 Category: Primary Care Tags: Endocrine Source Type: news

The risks of active surveillance for men with intermediate-risk prostate cancers
Men diagnosed with slow-growing prostate tumors that likely won’t be harmful during their lifetimes can often avoid immediate treatment. Instead, they can have their tumor monitored using a strategy called active surveillance. With this approach, doctors perform periodic checks for tumor progression and start treatment only if the cancer begins to metastasize, or spread. Active surveillance has become popular worldwide, but doctors still debate which groups of men can safely use this strategy. Some doctors offer it only to men with the lowest risk of cancer progression. Others say that men with intermediate-risk pros...
Source: New Harvard Health Information - May 27, 2016 Category: Consumer Health News Authors: Charlie Schmidt Tags: Cancer Men's Health Prostate Health Source Type: news

Scientists Block Breast Cancer Cells From Hiding in Bones
Contact: Samiha Khanna Phone: 919-419-5069 Email: samiha.khanna@duke.edu https://www.dukehealth.org EMBARGOED FOR RELEASE until 2 p.m. (ET) on WEDNESDAY, MAY 25, 2016 Scientists Block Breast Cancer Cells From Hiding in Bones DURHAM, N.C. -- Scientists at the Duke Cancer Institute have identified a molecular key that breast cancer cells use to invade bone marrow in mice, where they may be protected from chemotherapy or hormonal therapies that could otherwise eradicate them.  Through years of experiments in mice, the scientists have found ways to outmaneuver this stealth tactic by not only preventing breast cancer cells...
Source: DukeHealth.org: Duke Health Features - May 26, 2016 Category: Pediatrics Tags: Duke Medicine Source Type: news

GMC transgender advice could push GPs to prescribe beyond competence, warns GPC
GMC guidance that calls for GPs to initiate hormone therapy in some transgender patients before they see a specialist could make GPs 'feel coerced' into prescribing specialist drugs outside of their clinical competence, the GPC has warned. (Source: GP Online News)
Source: GP Online News - May 17, 2016 Category: Primary Care Tags: Clinical News Source Type: news

Radiotherapy halves deaths from prostate cancer 15 years after diagnosis
A study published in the journal European Urology shows that a combination of hormone therapy with local radiotherapy halves the risk of death from prostate cancer 15 years after diagnosis. Science Daily (Source: Society for Endocrinology)
Source: Society for Endocrinology - May 10, 2016 Category: Endocrinology Source Type: news

Prostate cancer drugs DOUBLE the risk of Alzheimer's... which sells even more drugs for Big Pharma
(NaturalNews) Prostate cancer patients who receive hormone therapy as part of their treatment are twice as likely to develop Alzheimer's and face an increased risk of depression, a pair of recent studies has shown.A common treatment for prostate cancer involves the use of androgen... (Source: NaturalNews.com)
Source: NaturalNews.com - May 4, 2016 Category: Consumer Health News Source Type: news

Compounded Non-FDA-approved Menopausal Hormone TherapyCompounded Non-FDA-approved Menopausal Hormone Therapy
What is compounded hormone therapy, are there specific risks with it, and how often is it being prescribed for menopausal women? Menopause (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 3, 2016 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health Journal Article Source Type: news

Is Pre- or Postmenopausal Hormonal Therapy OK After VTE? Is Pre- or Postmenopausal Hormonal Therapy OK After VTE?
Dr Goldhaber comments on an analysis of the EINSTEIN study suggesting that women with a history of DVT can take postmenopausal hormone therapy or oral contraceptives. theheart.org on Medscape (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 28, 2016 Category: Cardiology Tags: Cardiology Commentary Source Type: news

No increased risk of fatal cardiovascular events for breast cancer patients on newer hormone therapy
The use of aromatase inhibitors, hormone-therapy drugs used to treat patients with breast cancer, was not associated with an increased risk of fatal cardiovascular events, including heart attacks or stroke, compared with tamoxifen, another commonly prescribed anti-cancer drug that works on hormones and which has been associated with a serious risk of stroke, report investigators. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - April 21, 2016 Category: Science Source Type: news

Is Hormone Therapy Safe After Ovarian Cancer?
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - April 21, 2016 Category: Journals (General) Source Type: news

No increased risk of fatal CV events for breast cancer patients on newer hormone therapy
(Kaiser Permanente) In a new study from Kaiser Permanente, researchers found the use of aromatase inhibitors, hormone-therapy drugs used to treat patients with breast cancer, was not associated with an increased risk of fatal cardiovascular events, including heart attacks or stroke, compared with tamoxifen, another commonly prescribed anti-cancer drug that works on hormones and which has been associated with a serious risk of stroke. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 21, 2016 Category: Cancer & Oncology Source Type: news

Review Calls for More Research on Transgender Hormone Therapy Review Calls for More Research on Transgender Hormone Therapy
A new review details the benefits, risks, and effects of testosterone therapy in transgender men, highlighting the lack of long-term data and calling for more research that can help guide patient care. Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - April 20, 2016 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news

Hormone Therapy Safe After Ovarian CancerHormone Therapy Safe After Ovarian Cancer
Hormone therapy use after treatment for nonserous epithelial ovarian cancer was not tied to reduced overall survival, and may have extended disease-free survival in women younger than 55 years. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 20, 2016 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Source Type: news

Use of Compounded Hormone Therapy in the United StatesUse of Compounded Hormone Therapy in the United States
How many menopausal and postmenopausal women in the US are taking compounded hormone therapy, and how safe and effective is it? Menopause (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 19, 2016 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health Journal Article Source Type: news

Medical News Today: Prostate cancer hormone therapy may increase risk of depression
Men receiving androgen deprivation therapy for localized prostate cancer have a significantly higher risk of developing depression, according to a new study. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 13, 2016 Category: Consumer Health News Tags: Prostate / Prostate Cancer Source Type: news

Prostate cancer hormone therapy tied to higher depression risk
(Reuters Health) - Men who take hormone therapy for prostate cancer may have a higher risk of depression than patients who receive different treatment for these malignancies, a U.S. study suggests. (Source: Reuters: Health)
Source: Reuters: Health - April 12, 2016 Category: Consumer Health News Tags: healthNews Source Type: news

Can you stop a paedophile before they've abused a child?
A clinical trial is seeking crowd-funding to test hormone therapy drugs on paedophile volunteers to test whether it might help prevent abuse in the first place. BBC News (Source: Society for Endocrinology)
Source: Society for Endocrinology - April 12, 2016 Category: Endocrinology Source Type: news

Hormone Therapy for Prostate Cancer Tied to Depression
Title: Hormone Therapy for Prostate Cancer Tied to DepressionCategory: Health NewsCreated: 4/11/2016 12:00:00 AMLast Editorial Review: 4/12/2016 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - April 12, 2016 Category: Cancer & Oncology Source Type: news

Hormone Therapy for Prostate Cancer May Increase Risk of Depression
Study suggests androgen deprivation therapy for localized prostate cancer may increase the risk of depression (Source: BWH for Journalists)
Source: BWH for Journalists - April 12, 2016 Category: Research Source Type: news

Hormone Therapy for Prostate Cancer May Increase Risk of Depression
Study suggests androgen deprivation therapy for localized prostate cancer may increase the risk of depression (Source: BWH News)
Source: BWH News - April 12, 2016 Category: Hospital Management Source Type: news